StockData
AXIM Biotechnologies, Inc. logo

AXIM Biotechnologies, Inc. (AXIM) stock

AXIMOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2024, quarter ended Jun 30, 2024Last filing: 10-Q on Aug 19, 2024
$0.00+0.00 (+2.00%)

Close on Oct 19, 2026Market cap –P/E –Yield –

AXIM Biotechnologies gross profit

Gross profit is revenue minus the direct cost of the goods and services sold.

AXIM Biotechnologies's gross profit for the twelve months ending Sep 30, 2021 was $55.65K. For fiscal 2020 it was $0. The highest annual figure on record is $187.10K in fiscal 2018.

Annual gross profit

PeriodPeriod endValueChange
FY2020Dec 31, 2020$0–
FY2019Dec 31, 2019$0-100.0%
FY2018Dec 31, 2018$187.10K+3867.4%
FY2017Dec 31, 2017$4.72K–
FY2016Dec 31, 2016-$107.07K–
FY2015Dec 31, 2015-$1.25K–
FY2014Dec 31, 2014$0–

Quarterly gross profit

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2024Jun 30, 2024$15.74K+5.8%
Q2 FY2023Jun 30, 2023$9.93K-69.6%
Q3 FY2022Sep 30, 2022$1.31K–
Q3 FY2021Sep 30, 2021$8.13K–
Q2 FY2021Jun 30, 2021$14.88K–
Q1 FY2021Mar 31, 2021$32.65K–
Q4 FY2020Dec 31, 2020$0–
Q3 FY2020Sep 30, 2020$0-100.0%
Q1 FY2020Mar 31, 2020$0-100.0%
Q4 FY2019Dec 31, 2019$0-100.0%
Q3 FY2019Sep 30, 2019$0-100.0%
Q2 FY2019Jun 30, 2019$5.45K-7.6%
Q1 FY2019Mar 31, 2019$12.68K+1.1%
Q4 FY2018Dec 31, 2018$165.62K+1029.7%
Q3 FY2018Sep 30, 2018$3.05K-62.4%
Q2 FY2018Jun 30, 2018$5.89K+161.7%
Q1 FY2018Mar 31, 2018$12.54K–
Q4 FY2017Dec 31, 2017$14.66K–
Q3 FY2017Sep 30, 2017$8.11K–
Q2 FY2017Jun 30, 2017$2.25K–
Q1 FY2017Mar 31, 2017-$20.31K–
Q4 FY2016Dec 31, 2016-$100.96K–
Q3 FY2016Sep 30, 2016-$4.06K–
Q2 FY2016Jun 30, 2016-$841-106.9%
Q1 FY2016Mar 31, 2016-$1.21K–
Q4 FY2015Dec 31, 2015-$2.14K–
Q3 FY2015Sep 30, 2015-$11.22K–
Q2 FY2015Jun 30, 2015$12.11K–
Q1 FY2015Mar 31, 2015$0–
Q4 FY2014Dec 31, 2014$0–
Q3 FY2014Sep 30, 2014$0–

More AXIM Biotechnologies figures

See a number that looks wrong?